Processa Pharmaceuticals, Inc.

NasdaqCM:PCSA Stock Report

Market Cap: US$8.0m

Processa Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:PCSA Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
05 Aug 25BuyUS$1,243,784HX Entertainment LimitedCompany218,687.24US$5.69
05 Aug 25BuyUS$1,243,784HX Entertainment LimitedCompany218,687.24US$5.69
27 Jan 25BuyUS$34,691Patrick LinIndividual1,740US$19.94
27 Jan 25BuyUS$69,542George NgIndividual3,488US$19.94
27 Jan 25BuyUS$99,289David YoungIndividual4,980US$19.94
27 Jan 25BuyUS$9,889Justin YorkeIndividual496US$19.94

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of PCSA?
Owner TypeNumber of SharesOwnership Percentage
Private Companies4,7470.21%
Individual Insiders20,2680.895%
VC/PE Firms200,0008.83%
Institutions395,69517.5%
General Public1,645,05872.6%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 1633.9%.

Top Shareholders

Top 25 shareholders own 27.39% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
9.65%
HX Entertainment Limited
218,687US$767.6k0%no data
8.83%
Heights Capital Management, Inc.
200,000US$702.0k11.8%0.37%
4.67%
Armistice Capital LLC
105,775US$371.3k0%0.01%
1.82%
Stonepine Capital Management LLC
41,208US$144.6k0%0.07%
0.54%
Geode Capital Management, LLC
12,132US$42.6k500%no data
0.51%
The Vanguard Group, Inc.
11,528US$40.5k1,080%no data
0.42%
David Young
9,447US$33.2k5.32%no data
0.19%
George Ng
4,288US$15.1k0%no data
0.15%
Patrick Lin
3,289US$11.5k13.3%no data
0.1%
CorLyst, LLC
2,259US$7.9k0%no data
0.072%
Virtu Financial, Inc.
1,633US$5.7k-61%no data
0.064%
Two Sigma Securities, LLC
1,449US$5.1k0%no data
0.06%
Citigroup Inc.
1,362US$4.8k0%no data
0.059%
Sian Bigora
1,345US$4.7k53.7%no data
0.055%
Richland Fund LLC
1,249US$4.4k0%no data
0.055%
Young Plaisance Revocable Trust
1,239US$4.3k0%no data
0.047%
Wendy Guy
1,054US$3.7k122%no data
0.033%
Sterne Agee Asset Management, Inc.
758US$2.7k0%no data
0.028%
Justin Yorke
645US$2.3k0%no data
0.028%
Sassicaia Capital Advisers Llc
639US$2.2k0%no data
0.018%
Composition Wealth, LLC
400US$1.4k0%no data
0.0051%
Geraldine Pannu
115US$404.00%no data
0.0042%
Tower Research Capital Europe Limited
95US$333.2-3.06%no data
0.0025%
Khoso Baluch
56US$196.40%no data
0.0013%
James Neal
29US$101.80%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/12/26 15:32
End of Day Share Price 2025/12/24 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Processa Pharmaceuticals, Inc. is covered by 4 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Robin Garner KalleyCraig-Hallum Capital Group LLC
Raghuram SelvarajuH.C. Wainwright & Co.
Nazibur RahmanMaxim Group